Skip to main content

Cidara Therapeutics, Inc.

CDTXDelisted Jan 7, 2026
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001610618

Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.

13F holders, Q2 2024

Institutional positions in Cidara Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
26
−24 vs. Q1 2024
Shares held
1.42M
+313.5K (+28.4%) vs. Q1 2024Converted for a 1-for-20 split
Total value
$16.9M
−$3.42M (−16.9%) vs. Q1 2024
New holders
5
8 more added
Sold out
29
5 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 26 institutions
Q1 2021: 62 institutionsQ2 2021: 55 institutionsQ3 2021: 50 institutionsQ4 2021: 53 institutionsQ1 2022: 44 institutionsQ2 2022: 46 institutionsQ3 2022: 42 institutionsQ4 2022: 42 institutionsQ1 2023: 54 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 51 institutionsQ1 2024: 50 institutionsQ2 2024: 26 institutionsQ3 2024: 27 institutionsQ4 2024: 40 institutionsQ1 2025: 46 institutionsQ2 2025: 109 institutionsQ3 2025: 173 institutionsQ4 2025: 255 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $16.9M
Q1 2021: $56.6MQ2 2021: $40.5MQ3 2021: $42.1MQ4 2021: $39.5MQ1 2022: $25.2MQ2 2022: $13.3MQ3 2022: $17.1MQ4 2022: $20.2MQ1 2023: $34.4MQ2 2023: $29.7MQ3 2023: $22.7MQ4 2023: $18.4MQ1 2024: $20.3MQ2 2024: $16.9MQ3 2024: $35.6MQ4 2024: $183.6MQ1 2025: $205.9MQ2 2025: $1.26BQ3 2025: $3.11BQ4 2025: $7.36BQ1 2026: $0Q2 2026: $0
Institutions holding CDTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025255$7.36B
Q3 2025173$3.11B
Q2 2025109$1.26B
Q1 202546$205.9M
Q4 202440$183.6M
Q3 202427$35.6M
Q2 202426$16.9M
Q1 202450$20.3M
Q4 202351$18.4M
Q3 202352$22.7M
Q2 202352$29.7M
Q1 202354$34.4M
Q4 202242$20.2M
Q3 202242$17.1M
Q2 202246$13.3M
Q1 202244$25.2M
Q4 202153$39.5M
Q3 202150$42.1M
Q2 202155$40.5M
Q1 202162$56.6M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding CDTX in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Monashee Investment Management LLC369,099$4.41M0.57%+350,644+1,900.0%AddedConverted for a 1-for-20 split
BVF Inc343,055$4.10M0.11%00.0%UnchangedConverted for a 1-for-20 split
Vanguard Group Inc180,535$2.16M0.00%+13,222+7.9%AddedConverted for a 1-for-20 split
Checkpoint Capital L.P.145,417$1.74M1.05%+145,417New
Renaissance Technologies LLC95,517$1.14M0.00%−32,232−25.2%ReducedConverted for a 1-for-20 split
Alethea Capital Management, LLC79,908$954.1K0.72%00.0%UnchangedConverted for a 1-for-20 split
5AM Venture Management, LLC56,725$677.3K0.15%00.0%UnchangedConverted for a 1-for-20 split
BlackRock Inc.48,512$579.2K0.00%+12,742+35.6%AddedConverted for a 1-for-20 split
Geode Capital Management, LLC43,127$515.1K0.00%+1,213+2.9%AddedConverted for a 1-for-20 split
Schonfeld Strategic Advisors LLC19,400$231.6K0.00%−8,200−29.7%ReducedConverted for a 1-for-20 split
State Street Corp13,576$162.1K0.00%00.0%UnchangedConverted for a 1-for-20 split
US Bancorp13,103$156.4K0.00%00.0%UnchangedConverted for a 1-for-20 split
UBS Group AG1,467$17.5K0.00%+1,232+524.9%AddedConverted for a 1-for-20 split
Russell Investments Group, Ltd.855$10.2K0.00%00.0%UnchangedConverted for a 1-for-20 split
Tower Research Capital LLC (TRC)746$8.91K0.00%+294+64.9%AddedConverted for a 1-for-20 split
Manchester Capital Management LLC470$5.61K0.00%+470New
Pacifica Partners Inc.400$4.80K0.00%00.0%UnchangedConverted for a 1-for-20 split
Wetzel Investment Advisors, Inc.4,000$3.68K0.00%+3,800+1,900.0%AddedConverted for a 1-for-20 split
Morgan Stanley169$2.02K0.00%−611−78.3%ReducedConverted for a 1-for-20 split
JPMorgan Chase & Co106$1.27K0.00%+83+370.1%AddedConverted for a 1-for-20 split
Royal Bank of Canada67$1.00K0.00%+67New
Allworth Financial LP40$4730.00%00.0%UnchangedConverted for a 1-for-20 split
Bank of America Corp34$4060.00%+34New
BNP Paribas Arbitrage, SA17$2030.00%−1−3.7%ReducedConverted for a 1-for-20 split
Northwestern Mutual Wealth Management Co14$1670.00%+14New
Qube Research & Technologies Ltd2$240.00%−1−23.1%ReducedConverted for a 1-for-20 split
Point72 Asset Management, L.P.0$00.00%−62,500−100.0%Sold outConverted for a 1-for-20 split
Gsa Capital Partners LLP0$00.00%−22,830−100.0%Sold outConverted for a 1-for-20 split
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−15,842−100.0%Sold outConverted for a 1-for-20 split
Tocqueville Asset Management L.P.0$00.00%−8,150−100.0%Sold outConverted for a 1-for-20 split
Northern Trust Corp0$00.00%−8,018−100.0%Sold outConverted for a 1-for-20 split
Jeppson Wealth Management, LLC0$00.00%−7,433−100.0%Sold outConverted for a 1-for-20 split
West Michigan Advisors, LLC0$00.00%−6,750−100.0%Sold outConverted for a 1-for-20 split
Callan Capital, LLC0$00.00%−4,758−100.0%Sold outConverted for a 1-for-20 split
Citadel Advisors LLC0$00.00%−4,227−100.0%Sold outConverted for a 1-for-20 split
XTX Topco Ltd0$00.00%−3,951−100.0%Sold outConverted for a 1-for-20 split
Raymond James Financial Services Advisors, Inc.0$00.00%−3,878−100.0%Sold outConverted for a 1-for-20 split
Two Sigma Investments, LP0$00.00%−3,362−100.0%Sold outConverted for a 1-for-20 split
Pale Fire Capital SE0$00.00%−3,327−100.0%Sold outConverted for a 1-for-20 split
Bridgeway Capital Management, LLC0$00.00%−3,003−100.0%Sold outConverted for a 1-for-20 split
FNY Investment Advisers, LLC0$00.00%−2,830−100.0%Sold outConverted for a 1-for-20 split
Advisor Group Holdings, Inc.0$00.00%−2,632−100.0%Sold outConverted for a 1-for-20 split
Jane Street Group, LLC0$00.00%−2,287−100.0%Sold outConverted for a 1-for-20 split
Mackenzie Financial Corp0$00.00%−1,965−100.0%Sold outConverted for a 1-for-20 split
Legacy Wealth Asset Management, LLC0$00.00%−1,500−100.0%Sold outConverted for a 1-for-20 split
Charles Schwab Investment Management Inc0$00.00%−1,341−100.0%Sold outConverted for a 1-for-20 split
Two Sigma Advisers, LP0$00.00%−1,195−100.0%Sold outConverted for a 1-for-20 split
Prudential Financial Inc0$00.00%−600−100.0%Sold outConverted for a 1-for-20 split
Liberty Wealth Management LLC0$00.00%−600−100.0%Sold outConverted for a 1-for-20 split
Pure Financial Advisors, Inc.0$00.00%−575−100.0%Sold outConverted for a 1-for-20 split
Mariner, LLC0$00.00%−500−100.0%Sold outConverted for a 1-for-20 split
Spire Wealth Management0$00.00%−500−100.0%Sold outConverted for a 1-for-20 split
Wells Fargo & Company0$00.00%−32−100.0%Sold outConverted for a 1-for-20 split
Cubist Systematic Strategies, LLC0$00.00%−15−100.0%Sold outConverted for a 1-for-20 split
Simplex Trading, LLC0$00.00%−26−100.0%Sold outConverted for a 1-for-20 split